These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2109075)

  • 1. Experimental evidence of the benefit of misoprostol beyond the stomach in humans.
    Bjarnason I
    J Rheumatol Suppl; 1990 Feb; 20():38-41. PubMed ID: 2109075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of mucosal lesions in the stomach and duodenum due to chronic use of NSAID in patients with rheumatoid arthritis or osteoarthritis, and interim report on prevention by misoprostol of diclofenac associated lesions.
    Geis GS; Stead H; Wallemark CB; Nicholson PA
    J Rheumatol Suppl; 1991 Mar; 28():11-4. PubMed ID: 1903808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in defining the role of misoprostol in rheumatology.
    Nicholson PA
    J Rheumatol Suppl; 1990 Feb; 20():50-3. PubMed ID: 2109076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of misoprostol in upper gastro-intestinal lesions in arthritic patients on non-steroidal anti-inflammatory drugs (NSAIDS)--an Indian experience.
    Bhatt CB; Pipalia DH; Naik SR; Tilve GH
    J Postgrad Med; 1988 Oct; 34(4):224-8. PubMed ID: 3151214
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of oral adenosine 5'-triphosphate and adenosine in enteric-coated capsules on indomethacin-induced permeability changes in the human small intestine: a randomized cross-over study.
    Bours MJ; Bos HJ; Meddings JB; Brummer RJ; van den Brandt PA; Dagnelie PC
    BMC Gastroenterol; 2007 Jun; 7():23. PubMed ID: 17578566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Misoprostol: a prostaglandin for peptic ulcer.
    DiPalma JR
    Am Fam Physician; 1989 Aug; 40(2):217-9. PubMed ID: 2502901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The use of misoprostol in prevention of gastric disease from nonsteroidal anti-inflammatory drugs in oral-maxillofacial surgery].
    Bocca M; Giordano M; Del Pizzo M; Nelken A; Ghiggia M; Pomatto E
    Minerva Ortognatod; 1990; 8(2):139-41. PubMed ID: 2126183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of prostaglandins in NSAID induced renal dysfunction.
    Toto RD
    J Rheumatol Suppl; 1991 Mar; 28():22-5. PubMed ID: 1903810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local effect of adenosine 5'-triphosphate on indomethacin-induced permeability changes in the human small intestine.
    Bours MJ; Troost FJ; Brummer RJ; Bast A; Dagnelie PC
    Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):245-50. PubMed ID: 17301652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of gastrointestinal complications associated with nonsteroidal antiinflammatory drugs.
    Agrawal NM; Aziz K
    J Rheumatol Suppl; 1998 May; 51():17-20. PubMed ID: 9596550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients.
    Bianchi Porro G; Lazzaroni M; Petrillo M
    Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotec (misoprostol).
    Swartz ML
    Gastroenterol Nurs; 1990; 13(1):37-9. PubMed ID: 2126958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Underutilization of preventive strategies in patients receiving NSAIDs.
    Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
    Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic effects of prophylactic use of misoprostol to prevent gastric ulcer in patients taking nonsteroidal anti-inflammatory drugs.
    Hillman AL; Bloom BS
    Arch Intern Med; 1989 Sep; 149(9):2061-5. PubMed ID: 2505706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of candidates for adjunctive 'gastroprotective' prostaglandins.
    Adelizzi RA
    J Am Osteopath Assoc; 1990 Jul; 90(7):598-601. PubMed ID: 2115860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Misoprostol reduces indomethacin-induced changes in human small intestinal permeability.
    Bjarnason I; Smethurst P; Fenn CG; Lee CE; Menzies IS; Levi AJ
    Dig Dis Sci; 1989 Mar; 34(3):407-11. PubMed ID: 2493366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The therapeutic efficacy of misoprostol in peptic ulcer disease.
    Watkinson G; Hopkins A; Akbar FA
    Postgrad Med J; 1988; 64 Suppl 1():60-77. PubMed ID: 3138682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventing NSAID-induced ulcers: the use of misoprostol.
    Lynn MM; Holdcroft C
    Nurse Pract; 1990 Oct; 15(10):38-9, 42. PubMed ID: 2122334
    [No Abstract]   [Full Text] [Related]  

  • 19. Controversies, dilemmas, and dialogues. What do you recommend for prophylaxis in an elderly woman with arthritis requiring NSAIDs for control?
    Jones MP; Schubert ML; Smith JL
    Am J Gastroenterol; 1991 Mar; 86(3):264-8. PubMed ID: 1900141
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention of nonsteroidal anti-inflammatory drug-induced small-intestinal injury by prostaglandin: a pilot randomized controlled trial evaluated by capsule endoscopy.
    Fujimori S; Seo T; Gudis K; Ehara A; Kobayashi T; Mitsui K; Yonezawa M; Tanaka S; Tatsuguchi A; Sakamoto C
    Gastrointest Endosc; 2009 Jun; 69(7):1339-46. PubMed ID: 19243767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.